Architecture of ribonucleoprotein complexes in influenza A virus particles

University of California, Davis, Davis, California, United States
Nature (Impact Factor: 42.35). 02/2006; 439(7075):490-2. DOI: 10.1038/nature04378
Source: PubMed

ABSTRACT In viruses, as in eukaryotes, elaborate mechanisms have evolved to protect the genome and to ensure its timely replication and reliable transmission to progeny. Influenza A viruses are enveloped, spherical or filamentous structures, ranging from 80 to 120 nm in diameter. Inside each envelope is a viral genome consisting of eight single-stranded negative-sense RNA segments of 890 to 2,341 nucleotides each. These segments are associated with nucleoprotein and three polymerase subunits, designated PA, PB1 and PB2; the resultant ribonucleoprotein complexes (RNPs) resemble a twisted rod (10-15 nm in width and 30-120 nm in length) that is folded back and coiled on itself. Late in viral infection, newly synthesized RNPs are transported from the nucleus to the plasma membrane, where they are incorporated into progeny virions capable of infecting other cells. Here we show, by transmission electron microscopy of serially sectioned virions, that the RNPs of influenza A virus are organized in a distinct pattern (seven segments of different lengths surrounding a central segment). The individual RNPs are suspended from the interior of the viral envelope at the distal end of the budding virion and are oriented perpendicular to the budding tip. This finding argues against random incorporation of RNPs into virions, supporting instead a model in which each segment contains specific incorporation signals that enable the RNPs to be recruited and packaged as a complete set. A selective mechanism of RNP incorporation into virions and the unique organization of the eight RNP segments may be crucial to maintaining the integrity of the viral genome during repeated cycles of replication.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Influenza infections continue to present a major threat to public health. Traditional modes of influenza vaccine manufacturing are failing to satisfy the global demand because of limited scalability and long production timelines. In contrast, subunit vaccines (SUVs) can be produced in heterologous expression systems in shorter times and at higher quantities. Plants are emerging as a promising platform for SUV production due to time efficiency, scalability, lack of harbored mammalian pathogens and possession of the machinery for eukaryotic post-translational protein modifications. So far, several organizations have utilized plant-based transient expression systems to produce SUVs against influenza, including vaccines based on virus-like particles. Plant-produced influenza SUV candidates have been extensively evaluated in animal models and some have shown safety and immunogenicity in clinical trials. Here, the authors review ongoing efforts and challenges to producing influenza SUV candidates in plants and discuss the likelihood of bringing these products to the market.
    Expert Review of Vaccines 12/2014; DOI:10.1586/14760584.2015.989988 · 4.22 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Influenza A is a very important virus, it is widespread and it represents a major threat to the public health (it is nice to cite WHO: World Health Organization; One of the most important features of the Influenza A is its ability to mutate quite frequently (possess or demonstrate high genomic variability), thus successfully escaping either host's immune system action or anti-viral drugs action. Influenza A is obliged to its advanced segmented genome and to the diverse habitat for the observed and yet potential genomic variation. Influenza A evolve under a great number of selective pressures, while infecting various species [1], and this evolution makes it undergo a great number of evolutionary trajectories (visit many evolutionary " points " or states). Crossing species barriers by the virus makes the evolutionary variety even more reacher and broader, and is actually responsible for most of the influenza pandemics [2]. It is the segmented genome that allows influenza to cross species barriers so frequently, hosts infected with two or more strains could potentially produce novel strains with the genetic information being interchanged. It is believed that at particular steps of progeny virions assembly different segments or pieces of genetic information from different strains could happen to be interchangeable and thus could result in the reassorted genomes with a pandemic like properties. So, apparently the influenza genome packaging is the problem of a crucial importance, which is not yet fully understood, particularly it is the molecular mechanism understanding what is missing. What is actually known about the influenza genome packaging and other life cycle elements related to this problem? Influenza genome is stored in the form of negative stranded RNA segments, that are packed with a set of proteins in the form of vRNPs (ribonucleoprotein complexes) and enveloped with a piece of a lipid membrane, forming a virion [3]. There are 8 unique RNA segments (actually genes, some people call them chromosomes) carrying influenza A genetic information: segment 1 (PB2), seg-ment2 (PB1 and derivatives), segment 3 (PA, PA-X), segment 4 (HA), segment 5 (NP), segment 6 (NA), segment 7 (M1,M2), segment 8 (NS1,NEP) [3]. Each segment in the form of vRNP represents an independent functional unit for transcription and replication [4]. Every vRNP carries a trimeric polymerase complex along with a set of structure forming nucleoproteins and the vRNA [4, 5]. Structural studies show that vRNPs have an elongated rod-like form with length approximately proportional to the corresponding vRNA segment length (from around 900 to around 2300 nt) [6, 7] (Kawaoka et al. in *
  • [Show abstract] [Hide abstract]
    ABSTRACT: In China, the recent outbreak of novel influenza A/H7N9 virus has been assumed to be severe, and it may possibly turn brutal in the near future. In order to develop highly protective vaccines and drugs for the A/H7N9 virus, it is critical to find out the selection pressure of each amino acid site. In the present study, six different statistical methods consisting of four independent codon-based maximum likelihood (CML) methods, one hierarchical Bayesian (HB) method and one branch-site (BS) method, were employed to determine if each amino acid site of A/H7N9 virus is under natural selection pressure. Functions for both positively and negatively selected sites were inferred by annotating these sites with experimentally verified amino acid sites. Comprehensively, the single amino acid site 627 of PB2 protein was inferred as positively selected and it function was identified as a T-cell epitope (TCE). Among the 26 negatively selected amino acid sites of PB2, PB1, PA, HA, NP, NA, M1 and NS2 proteins, only 16 amino acid sites were identified to be involved in TCEs. In addition, 7 amino acid sites including, 608 and 609 of PA, 480 of NP, and 24, 25, 109 and 205 of M1, were identified to be involved in both B-cell epitopes (BCEs) and TCEs. Conversely, the function of positions 62 of PA, and, 43 and 113 of HA was unknown. In conclusion, the seven amino acid sites engaged in both BCEs and TCEs were identified as highly suitable targets, as these sites will be predicted to play a principal role in inducing strong humoral and cellular immune responses against A/H7N9 virus.
    Genomics 11/2014; 104(6). DOI:10.1016/j.ygeno.2014.10.012 · 2.79 Impact Factor

Full-text (2 Sources)

Available from
Jun 4, 2014